Precipio Inc Sustainability Reports
Precipio, Inc. is a healthcare biotechnology company that develops and provides specialized blood cancer diagnostic products and pathology testing services. Its proprietary platforms include HemeScreen genetic diagnostic panels and IV-Cell cell culture media to reduce laboratory misdiagnoses.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930079ULTBRXUQNR89
FIGI: BBG001SF2K06
4 reports from 2020 to 2025
